197 related articles for article (PubMed ID: 17653964)
1. The NAD(P)H oxidase inhibitor apocynin improves endothelial NO/superoxide balance and lowers effectively blood pressure in spontaneously hypertensive rats: comparison to calcium channel blockade.
Bäumer AT; Krüger CA; Falkenberg J; Freyhaus HT; Rösen R; Fink K; Rosenkranz S
Clin Exp Hypertens; 2007 Jul; 29(5):287-99. PubMed ID: 17653964
[TBL] [Abstract][Full Text] [Related]
2. Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat.
Hu L; Zhang Y; Lim PS; Miao Y; Tan C; McKenzie KU; Schyvens CG; Whitworth JA
Am J Hypertens; 2006 Apr; 19(4):413-8. PubMed ID: 16580579
[TBL] [Abstract][Full Text] [Related]
3. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity.
Vera R; Sánchez M; Galisteo M; Villar IC; Jimenez R; Zarzuelo A; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2007 Feb; 112(3):183-91. PubMed ID: 17007611
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species.
Lijnen P; Papparella I; Petrov V; Semplicini A; Fagard R
J Hypertens; 2006 Apr; 24(4):757-66. PubMed ID: 16531806
[TBL] [Abstract][Full Text] [Related]
6. Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase.
Adler S; Huang H
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F907-13. PubMed ID: 15475543
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats.
Kawczynska-Drozdz A; Olszanecki R; Jawien J; Brzozowski T; Pawlik WW; Korbut R; Guzik TJ
Am J Hypertens; 2006 Jul; 19(7):764-7. PubMed ID: 16814134
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease.
Sartori-Valinotti JC; Iliescu R; Fortepiani LA; Yanes LL; Reckelhoff JF
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):938-45. PubMed ID: 17645644
[TBL] [Abstract][Full Text] [Related]
10. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits.
Chan EC; Datla SR; Dilley R; Hickey H; Drummond GR; Dusting GJ
Cardiovasc Res; 2007 Sep; 75(4):710-8. PubMed ID: 17659266
[TBL] [Abstract][Full Text] [Related]
11. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase.
Ungvari Z; Csiszar A; Huang A; Kaminski PM; Wolin MS; Koller A
Circulation; 2003 Sep; 108(10):1253-8. PubMed ID: 12874194
[TBL] [Abstract][Full Text] [Related]
12. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta.
Loomis ED; Sullivan JC; Osmond DA; Pollock DM; Pollock JS
J Pharmacol Exp Ther; 2005 Dec; 315(3):1058-64. PubMed ID: 16144972
[TBL] [Abstract][Full Text] [Related]
13. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.
Zhang Y; Chan MM; Andrews MC; Mori TA; Croft KD; McKenzie KU; Schyvens CG; Whitworth JA
Am J Hypertens; 2005 Jul; 18(7):910-6. PubMed ID: 16053986
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction.
Hayashi T; Juliet PA; Kano-Hayashi H; Tsunekawa T; Dingqunfang D; Sumi D; Matsui-Hirai H; Fukatsu A; Iguchi A
Diabetes Obes Metab; 2005 Jul; 7(4):334-43. PubMed ID: 15955119
[TBL] [Abstract][Full Text] [Related]
15. Apocynin normalizes hyperreactivity to phenylephrine in mesenteric arteries from cholesterol-fed mice by improving endothelium-derived hyperpolarizing factor response.
Matsumoto T; Miyamori K; Kobayashi T; Kamata K
Free Radic Biol Med; 2006 Oct; 41(8):1289-303. PubMed ID: 17015176
[TBL] [Abstract][Full Text] [Related]
16. Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats.
Suzuki A; Yamamoto N; Jokura H; Yamamoto M; Fujii A; Tokimitsu I; Saito I
J Hypertens; 2006 Jun; 24(6):1065-73. PubMed ID: 16685206
[TBL] [Abstract][Full Text] [Related]
17. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension.
Pechánová O; Zicha J; Paulis L; Zenebe W; Dobesová Z; Kojsová S; Jendeková L; Sládková M; Dovinová I; Simko F; Kunes J
Eur J Pharmacol; 2007 Apr; 561(1-3):129-36. PubMed ID: 17321519
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus.
Mayhan WG; Arrick DM; Sharpe GM; Patel KP; Sun H
Microcirculation; 2006; 13(7):567-75. PubMed ID: 16990215
[TBL] [Abstract][Full Text] [Related]
19. Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats.
Yamamoto M; Suzuki A; Jokura H; Yamamoto N; Hase T
Nutrition; 2008 May; 24(5):470-6. PubMed ID: 18329851
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production.
Shinozaki K; Nishio Y; Ayajiki K; Yoshida Y; Masada M; Kashiwagi A; Okamura T
J Cardiovasc Pharmacol; 2007 Mar; 49(3):122-30. PubMed ID: 17414223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
